Markets

Cybin Inc. To Officially Change Name To Helus Pharma Inc. Effective October 1, 2026

Sep 22, 2026 · 05:30 PM ET· updated 1h ago

Helus Pharma (NASDAQ:HELP) (Cboe CA: HELP) ("Helus" or the "Company"), a clinical-stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists ("NSAs"),

Why It Matters

Cybin is changing its company name to Helus Pharma on October 1, 2026. When a company rebrand like this happens, pay attention to what they focus on next and how investors react.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

HELP13.81

+0.15 (+1.09%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.